Authored by: Jon Carson, Iain Farrance, John Getz, and Jon A. Rowley, RoosterBio, Inc. On 31-December-2019, Chinese officials alerted the World Health Organization of an outbreak of pneumonia cases in ... More
Authored by: Katrina Adlerz, PhD, Scientist, Analytical, Process & Product Development, RoosterBio Scalability of EV Manufacturing is a Major Challenge Previously, we discussed the emergence of MSC extracellular vesicles (EVs) ... More
Authored by Josephine Lembong, Ph.D., Scientist, Product & Process Development & Jon Rowley, Ph.D., Founder and Chief Product Officer, RoosterBio Inc. Previously, we published a blog post on estimating hMSC ... More
Authored by Josephine Lembong, Ph.D., Scientist, Product & Process Development & Jon A. Rowley, Ph.D., Founder and Chief Product Officer, RoosterBio Inc. Jon Rowley, RoosterBio’s Founder and Chief Product Officer, gave a talk at ... More
Contributed by: Timothy R. Olsen, Ph.D. – Sr. Scientist, Process and Product Development at RoosterBio Inc. After the National Institute for Standards and Technology (NIST) identified upcoming challenges in the U.S. ... More
Introduction RoosterBio is introducing a new product for highly efficient bioreactor expansion of human Mesenchymal Stem/Stromal Cells (hMSCs) that we are calling RoosterReplenish™-MSC. This innovative, first-in-class stem cell product is ... More